Simplified Insulin Protocol Using Lantus in Elderly

Completed · Phase 4

Conditions studied: Diabetes

In brief

The purpose of this study is to find out if simplifying your diabetes treatment by decreasing number of insulin injections, with the help of a long acting insulin called glargine, can decrease the episodes of low blood glucose.

Key facts

Study ID

NCT01480843

Run by

Joslin Diabetes Center

People needed

65

Starts

2011-06-01

Expected to finish

2015-09-01

Last updated by the study team

2017-11-08

Who can join

Age: 70 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 70 years or older
• Diagnosis of diabetes mellitus Type II
• At least 2 (short-acting or mixed) insulin injections per day
• At least 1 episode of hypoglycemia (glucose value <70) on screening CGM

You may not qualify if…

• Patients with the following illnesses in the past 12 months Myocardial infarction Angina Coronary artery bypass grafting Percutaneous transluminal coronary angiography Cerebrovascular event (stroke, TIA)
• Active liver disease (history of cirrhosis or LFT > 3 times normal)
• On dialysis or with severe renal dysfunction (creatinine clearance <20 ml/min)
• Malignancy that limits life span to less than 18 months
• Patients seen in the geriatric clinic who already have simplified regimen as proposed in the study

Where it is running

• Joslin Diabetes Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.